Theralase Release FY2021 Audited Financial Statements

Written by Customer Service on April 30, 2022. Posted in Earnings Releases And Operating Results.

TORONTO, April 29, 2022 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated PhotoDynamic Compounds (“PDC”) and their associated drug formulations intended to safely and effectively destroy various cancers released its audited annual consolidated 2021 financial statements. Financial Highlights: For the years ended December 31st: Audited Consolidated Statements of Operations In Canadian Dollars 2021 2020 % Change Revenue Canada 697,727 815,159 -14 % United States 69,725 87,923 -21 % International 13,189 26,040 -49 % Total Revenue 780,641 929,122 -16 % Cost of Sales 470,698 659,442 -29 % Gross Margin 309,943 269,680 15 % Gross...

Candelaria Announces Grant of Options and Restricted Share Units

Written by Customer Service on April 30, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, April 29, 2022 (GLOBE NEWSWIRE) — Candelaria Mining Corp. (TSX-V: CAND, OTC PINK: CDELF) (the “Company”) announces that pursuant to the Company’s stock option plan and restricted share unit plan (together, the “Plans”), the Company granted today a total of 4,120,000 stock options (“Options”) and 461,677 restricted share units (“RSUs”) to directors, officers, employees and consultants of the Company. Each Option is exercisable into one common share of the Company for period of five years at an exercise price of $0.14 per share. All Options vest as follows: one-third after six months from the grant date, one-third at 12 months from the grant date and one-third at 18 months from the grant date. All RSU’s vest at one year from the grant date. All Options and RSUs are subject to the terms of the Company’s...

Canadian Spirit Resources Inc. Announces Year End 2021 Financial Results

Written by Customer Service on April 30, 2022. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, April 29, 2022 (GLOBE NEWSWIRE) — Canadian Spirit Resources Inc. (“CSRI” or the “Corporation”) (TSXV:SPI) (OTCBB:CSPUF) announces the release of its financial results for the three and twelve months ended December 31, 2021 including the filing of its 2021 annual audited Financial Statements, Management Discussion and Analysis (“MD&A”), and Forms 51- 101F1, F2 and F3. This news release summarizes information contained in the audited Financial Statements and MD&A for the year ended December 31, 2021 and should not be considered a substitute for reading these full disclosure documents, and the Forms 51-101F1, F2 and F3, which are available on SEDAR at www.sedar.com or the Corporation’s website at www.csri.ca. CSRI is a natural resources company focused on the identification and...

Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults

Written by Customer Service on April 30, 2022. Posted in Public Companies.

First novel, nonstimulant option for adults with ADHD in 20 years ADHD affects an estimated 10 million adults in the U.S. ROCKVILLE, Md., April 29, 2022 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that the U.S. Food and Drug Administration (FDA) approved an expanded indication for Qelbree (viloxazine extended-release capsules) for the treatment of attention deficit hyperactivity disorder (ADHD) in adult patients aged 18 and older. The FDA has now approved Qelbree for the treatment of ADHD in children (starting at age 6), adolescents and adults. Approximately 16 million children, adolescents, and adults have ADHD in the U.S. While many children with ADHD outgrow...

Bilibili Provides Updates on Financial Guidance and Recent Business Developments

Written by Customer Service on April 30, 2022. Posted in Public Companies.

Company to Host First Quarter 2022 Financial Results Conference Call on June 9 at 8:00 AM ET SHANGHAI, China, April 29, 2022 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that it has updated its net revenues guidance for the first quarter of 2022 and provided an update on the Company’s recent developments. With macro-economic disruption caused by the unexpected Covid-19 resurgence nationwide in China, and the increased Covid-19 restrictions and lockdowns in major cities including Shanghai since mid-March, the Company currently expects net revenues for the first quarter of 2022 to be in the range of RMB5.0 billion to RMB5.1 billion. This compares with the range of RMB5.3 billion to RMB5.5...

Day: April 30, 2022